Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Head & Neck 5

Conditions

Parathyroid Neoplasms 5Hyperparathyroidism, Primary 3

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Parathyroidectomy × Clear all
NCT06913296 2025-04-06

PTeye in Parathyroid Adenoma

Aristotle University Of Thessaloniki

Recruiting
50 enrolled
Head & Neck

Parathyroid Neoplasms

NCT06788223 2025-01-24

PTeye

Aristotle University Of Thessaloniki

Active not recruiting
40 enrolled
Head & Neck

Parathyroid Neoplasms

NCT06779760 2025-01-17

NIRAF MIVAP

Aristotle University Of Thessaloniki

Completed
24 enrolled
Head & Neck

Parathyroid Neoplasms, Hyperparathyroidism, Primary

NCT05789680 2023-03-29

EMS-PC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Unknown
17 enrolled
Head & Neck

Parathyroid Neoplasms, Hyperparathyroidism, Primary

NCT03011736 2021-08-12

Omission of Intact Parathyroid Hormone Testing During Surgery in Treating Patients With Primary Hyperparathyroidism

Roswell Park Cancer Institute

Phase NA Completed
6 enrolled
Head & Neck

Parathyroid Neoplasms, Hyperparathyroidism, Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡